Shares of Neonc Technologies Holdings, Inc. (NASDAQ:NTHI – Get Free Report) dropped 15.7% during trading on Tuesday . The stock traded as low as $10.10 and last traded at $11.26. Approximately 39,700 shares changed hands during mid-day trading, a decline of 11% from the average daily volume of 44,725 shares. The stock had previously closed at $13.36.
Neonc Technologies Trading Up 36.9 %
About Neonc Technologies
Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing.
Featured Articles
- Five stocks we like better than Neonc Technologies
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- What is the S&P 500 and How It is Distinct from Other Indexes
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- What is the Nasdaq? Complete Overview with History
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Receive News & Ratings for Neonc Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neonc Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
